From 2013 to 2023, the pharmaceutical imports in Poland have shown significant fluctuation, peaking at $8.93 billion in 2023. This represents an increase of 2.77% year-on-year from 2022, and a 5-year CAGR of 3.03%, indicating a moderate upward trend. Notable spikes occurred in 2018, 2020, and decreasing growth rates in 2019 and 2021.
Future trends to watch for:
• Continued moderate growth with a forecasted CAGR of 1.91% over the next five years.
• Increasing demand for innovative and specialty pharmaceuticals.
• Potential impact of healthcare policies and trade regulations on import values.
• Influence of technology and digital transformation in pharma logistics and supply chain efficiency.
